Increasing prevalence of cirrhosis among U.S. adults aware or unaware of their chronic hepatitis C virus infection

Journal of Hepatology

Volumn 64, Issue 5, 2016, Pages 1027-1032

  Udompap, Prowpanga ^a   Mannalithara, Ajitha ^a   Heo, Nae Yun ^a,b   Kim, Donghee ^a   Kim, W Ray ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Inje University College of Medicine   (South Korea)

Author keywords

Cirrhosis.; Hepatitis C virus; Liver fibrosis

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; VIRUS RNA;

ADULT; AGE; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; AWARENESS; CHRONIC HEPATITIS C; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HEPATITIS C VIRUS; HUMAN; LIVER CIRRHOSIS; LIVER FIBROSIS; MAJOR CLINICAL STUDY; MALE; OBESITY; PREVALENCE; PRIORITY JOURNAL; THROMBOCYTE COUNT; UNITED STATES; COMPLICATION; FOLLOW UP; GENETICS; HEPACIVIRUS; HEPATITIS C, CHRONIC; MASS SCREENING; MIDDLE AGED; ODDS RATIO; PROCEDURES; RETROSPECTIVE STUDY; RISK FACTOR; VIROLOGY; YOUNG ADULT;

ADULT; FEMALE; FOLLOW-UP STUDIES; HEPACIVIRUS; HEPATITIS C, CHRONIC; HUMANS; LIVER CIRRHOSIS; MALE; MASS SCREENING; MIDDLE AGED; ODDS RATIO; PREVALENCE; RETROSPECTIVE STUDIES; RISK FACTORS; RNA, VIRAL; UNITED STATES; YOUNG ADULT;

EID: 84975686341     PISSN: 01688278     EISSN: 16000641     Source Type: Journal    
DOI: 10.1016/j.jhep.2016.01.009     Document Type: Article

References (32)

1. M.M. Denniston, R.B. Jiles, J. Drobeniuc, R.M. Klevens, J.W. Ward, G.M. McQuillan, and et al. Chronic hepatitis C virus infection in the United States, National Health and Nutrition Examination Survey 2003 to 2010 Ann Intern Med 160 2014 293 300
2. K.N. Ly, J. Xing, R.M. Klevens, R.B. Jiles, J.W. Ward, and S.D. Holmberg The increasing burden of mortality from viral hepatitis in the United States between 1999 and 2007 Ann Intern Med 156 2012 271 278
3. M.M. Denniston, R.M. Klevens, G.M. McQuillan, and R.B. Jiles Awareness of infection, knowledge of hepatitis C, and medical follow-up among individuals testing positive for hepatitis C: National Health and Nutrition Examination Survey 2001-2008 Hepatology 55 2012 1652 1661
4. A.J. van der Meer, B.J. Veldt, J.J. Feld, H. Wedemeyer, J.F. Dufour, F. Lammert, and et al. Association between sustained virological response and all-cause mortality among patients with chronic hepatitis C and advanced hepatic fibrosis JAMA 308 2012 2584 2593
5. G.L. Davis, M.J. Alter, H. El-Serag, T. Poynard, and L.W. Jennings Aging of hepatitis C virus (HCV)-infected persons in the United States: a multiple cohort model of HCV prevalence and disease progression Gastroenterology 138 2010 513 521 521, e511-e516
6. Centers for Disease Control and Prevention. 2001-2002 Lab Methods. [cited; Available from: http://www.cdc.gov/nchs/nhanes/nhanes2001-2002/lab-methods-01-02.htm Last accessed: April 1, 2015].
7. Centers for Disease Control and Prevention. NHANES III LABORATORY DATA FILE DOCUMENTATION. [cited; Available from: ftp://ftp.cdc.gov/pub/Health-Statistics/NCHS/nhanes/nhanes3/1A/lab-acc.pdf. Last accessed: April 1, 2015].
8. G.N. Ioannou, E.J. Boyko, and S.P. Lee The prevalence and predictors of elevated serum aminotransferase activity in the United States in 1999-2002 Am J Gastroenterol 101 2006 76 82
9. S.M. Martinez, G. Crespo, M. Navasa, and X. Forns Noninvasive assessment of liver fibrosis Hepatology 53 2011 325 335
10. C.T. Wai, J.K. Greenson, R.J. Fontana, J.D. Kalbfleisch, J.A. Marrero, H.S. Conjeevaram, and et al. A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C Hepatology 38 2003 518 526
11. R.K. Sterling, E. Lissen, N. Clumeck, R. Sola, M.C. Correa, J. Montaner, and et al. Development of a simple noninvasive index to predict significant fibrosis in patients with HIV/HCV coinfection Hepatology 43 2006 1317 1325
12. J. Li, S.C. Gordon, L.B. Rupp, T. Zhang, J.A. Boscarino, V. Vijayadeva, and et al. The validity of serum markers for fibrosis staging in chronic hepatitis B and C J Viral Hepat 21 2014 930 937
13. E. Teshale, M. Lu, L.B. Rupp, S.D. Holmberg, A.C. Moorman, P. Spradling, and et al. APRI and FIB-4 are good predictors of the stage of liver fibrosis in chronic hepatitis B: the Chronic Hepatitis Cohort Study (CHeCS) J Viral Hepat 21 2014 917 920
14. L. de Lucca Schiavon, J.L. Narciso-Schiavon, and R.J. de Carvalho-Filho Non-invasive diagnosis of liver fibrosis in chronic hepatitis C World J Gastroenterol 20 2014 2854 2866
15. Centers for Disease Control and Prevention. ANALYTIC AND REPORTING GUIDELINES: The Third National Health and Nutrition Examination Survey, NHANES III (1988-94). [cited; Available from: http://www.cdc.gov/nchs/data/nhanes/nhanes3/nh3gui.pdf Last accessed: April 1, 2015].
16. Centers for Disease Control and Prevention. ANALYTIC AND REPORTING GUIDELINES. [cited; Available from: http://www.cdc.gov/nchs/data/nhanes/nhanes-03-04/nhanes-analytic-guidelines-dec-2005.pdf. Last accessed: April 1, 2015].
17. G. Lutchman, and W.R. Kim A glass half full: Implications of screening for hepatitis C virus in the era of highly effective antiviral therapy Hepatology 61 2015 1455 1458
18. R.L. Koretz, K.W. Lin, J.P. Ioannidis, and J. Lenzer Is widespread screening for hepatitis C justified? BMJ 350 2015 g7809
19. I. Ditah, F. Ditah, P. Devaki, O. Ewelukwa, C. Ditah, B. Njei, and et al. The changing epidemiology of hepatitis C virus infection in the United States: National Health and Nutrition Examination Survey 2001 through 2010 J Hepatol 60 2014 691 698
20. E. Chak, A.H. Talal, K.E. Sherman, E.R. Schiff, and S. Saab Hepatitis C virus infection in USA: an estimate of true prevalence Liver Int 31 2011 1090 1101
21. A.C. Moorman, J. Xing, S. Ko, L.B. Rupp, F. Xu, S.C. Gordon, and et al. Late diagnosis of hepatitis C virus infection in the Chronic Hepatitis Cohort Study (CHeCS): Missed opportunities for intervention Hepatology 61 2015 1479 1484
22. L.J. McGarry, V.S. Pawar, H.R. Panchmatia, J.L. Rubin, G.L. Davis, Z.M. Younossi, and et al. Economic model of a birth cohort screening program for hepatitis C virus Hepatology 55 2012 1344 1355
23. H. Razavi, A.C. Elkhoury, E. Elbasha, C. Estes, K. Pasini, T. Poynard, and et al. Chronic hepatitis C virus (HCV) disease burden and cost in the United States Hepatology 57 2013 2164 2170
24. F. Kanwal, T. Hoang, J.R. Kramer, S.M. Asch, M.B. Goetz, A. Zeringue, and et al. Increasing prevalence of HCC and cirrhosis in patients with chronic hepatitis C virus infection Gastroenterology 140 2011 e1181
25. H.H. Thein, Q. Yi, G.J. Dore, and M.D. Krahn Estimation of stage-specific fibrosis progression rates in chronic hepatitis C virus infection: a meta-analysis and meta-regression Hepatology 48 2008 418 431
26. D.B. Rein, J.S. Wittenborn, C.M. Weinbaum, M. Sabin, B.D. Smith, and S.B. Lesesne Forecasting the morbidity and mortality associated with prevalent cases of pre-cirrhotic chronic hepatitis C in the United States Dig Liver Dis 43 2011 66 72
27. V.A. Moyer Force USPST. Screening for hepatitis C virus infection in adults: U.S. Preventive Services Task Force recommendation statement Ann Intern Med 159 2013 349 357
28. Recommendations for prevention and control of hepatitis C virus (HCV) infection and HCV-related chronic disease. Centers for Disease Control and Prevention. MMWR Recommendations and reports: Morbidity and mortality weekly report Recommendations and reports/Centers for Disease Control 47 1998 1 39
29. R. Chou, E.B. Cottrell, N. Wasson, B. Rahman, and J.M. Guise Screening for hepatitis C virus infection in adults: a systematic review for the U.S. Preventive Services Task Force Ann Intern Med 158 2013 101 108
30. S.D. Holmberg, M. Lu, L.B. Rupp, L.E. Lamerato, A.C. Moorman, V. Vijayadeva, and et al. Noninvasive serum fibrosis markers for screening and staging chronic hepatitis C virus patients in a large US cohort Clin Infect Dis 57 2013 240 246
31. T. Poynard, J. McHutchison, M. Manns, C. Trepo, K. Lindsay, Z. Goodman, and et al. Impact of pegylated interferon alfa-2b and ribavirin on liver fibrosis in patients with chronic hepatitis C Gastroenterology 122 2002 1303 1313
32. T. Poynard, P. Bedossa, and P. Opolon Natural history of liver fibrosis progression in patients with chronic hepatitis C Lancet 349 1997 825 832